Nellcor Puritan Bennett, Inc. v. Masimo Corp.

300 F. Supp. 2d 923, 2004 U.S. Dist. LEXIS 4468, 2004 WL 117468
CourtDistrict Court, C.D. California
DecidedJanuary 21, 2004
DocketCV 03-0603 MRP
StatusPublished
Cited by3 cases

This text of 300 F. Supp. 2d 923 (Nellcor Puritan Bennett, Inc. v. Masimo Corp.) is published on Counsel Stack Legal Research, covering District Court, C.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Nellcor Puritan Bennett, Inc. v. Masimo Corp., 300 F. Supp. 2d 923, 2004 U.S. Dist. LEXIS 4468, 2004 WL 117468 (C.D. Cal. 2004).

Opinion

MEMORANDUM OF DECISION RE: Masimo’s Motion for Summary Judgment of Noninfringement of U.S. Patent 4,934,372

PFAELZER, District Judge.

Background

Plaintiffs Nellcor Puritan Bennett, Inc. and Mallinckrodt, Inc. (collectively “Nell-cor”) and Defendant Masimo Corporation (“Masimo”) are engaged in manufacturing and selling equipment used in pulse oxime-try. Pulse oximetry involves measuring a patient’s heart and lung function via a noninvasive procedure that calculates pulse and arterial blood oxygen saturation. A pulse-oximeter includes a photo-emitter that sends light through a patient’s tissue, a photodetector that measures the light transmitted through the tissue, and a monitor that computes the patient’s blood oxygen saturation from the measured data.

Nellcor alleges that Masimo infringes U.S. Patent No. 4,934,372 (the “ ’372 patent”). 1 Nellcor attempted to assert this patent in another case before this Court, Mallinckrodt, Inc. et al. v. Masimo Corp. (CV-00-6506) (“the Consolidated Cases”). On July 15, 2002, this Court denied Nellcor leave to add the alleged infringement of the ’372 patent to its Complaint in the Consolidated Cases. In this action, Nell-cor asserts the infringement claims relating to the ’372 patent that they were not permitted to bring into the Consolidated Cases.

On December 1, 2003 Masimo filed a Motion for Summary Judgment supported by a memorandum (“Masimo Mot.”) and declarations (“Lateef Decl.” and “Diab Deck” (filed under seal)). Nellcor filed its Opposition (“Nellcor Opp.” (filed under seal)) and declaration (“Corenman Deck” (filed under seal)) on December 18, 2003. On January 5, 2003, Masimo filed a Reply and declaration (“Oldham Deck”). The Court heard this Motion on January 12, 2003, and took the matter under submission. For the reasons outlined below, this Court GRANTS Masimo’s Motion for Summary Judgment for non-infringement.

Technology

I. Patent Claims at Issue

Both the claims of Masimo and of Nell-cor relate to the pulse oximeter. Nellcor asserts that Masimo’s products, including, without limitation, Masimo’s RadicalTM and Rad-9TM pulse oximeters and MS circuit boards, infringe Claims 1, 2, 20 and 21 of Nellcor’s ’372 patent. Claims 1 and 20 are independent claims.

A. Claim 1

Claim 1 claims “a method for calculating the amount of a blood constituent from the blood flow characteristics of a patient.” ’372 patent col. 59: 19-21. Claim 1 *927 includes the element of “processing the time-measure collectively to determine a composite waveform ... so that the aperiodic information is attenuated and filtered from the composite.” Id. at 34-40 (emphasis added). Claim 1 also includes a method for determining oxygen saturation that “calculates] the amount of blood constituent from the relative maximum and minimum amplitude of the composite periodic waveforms of the detected wavelengths.” Id. at 41-44 (emphasis added).

B. Claim 20

Claim 20 includes similar limitations, but is structured in a means-plus-function format, where the functions are the steps of Claim 1.

II. Removal of Aperiodic Noise

Claims 1 and 20 of ’372 require a specific software routine for filtering out noise from the signals and then calculating oxygen saturation. Nellcor claims that the software routine used in Masimo’s oxime-ters, the chirp-z routine, causes Masimo’s oximeters to infringe. The chirp-z routine transforms patient signals from the time domain into the frequency domain. 2 Nell-cor contends that Masimo’s chirp-z routine infringes the ’372 patent because it involves the same processes as used in the ’372 patent to reduce the aperiodic information from the signals.

Specifically, Nellcor alleges that the transformation from time to frequency domain in Masimo’s patent involves the “sum[mation] of amplitudes of the periodic signal at the periodic frequency, while spreading the amplitude of the aperiodic information across the frequency spectrum.” Nellcor Opp. at 7. Nellcor alleges that the “aperiodic information is reduced in comparison to the desired, periodic information.” Id. This process is identical to that Nellcor claims as its own.

Masimo disagrees with Nellcor, and asserts that Masimo’s products do not infringe because Nellcor’s ’372 patent requires that the aperiodic information be “reduced and removed” prior to calculation, whereas Masimo’s patent does not. Masimo further alleges that it does not use the minimum amplitude or zero-frequency measure in the calculation of oxygen saturation, while the Nellcor patent requires the use of both the maximum and the minimum amplitudes in the calculation.

Standard of Review

Summary judgment is appropriate when the submissions show that “there is no genuine issue as to any material fact and ... the moving party is entitled to a judgment as a matter of law.” Fed.R.Civ.P. 56(c); Celotex Corp. v. Catrett, 477 U.S. 317, 322-26, 106 S.Ct. 2548, 91 L.Ed.2d 265 (1986). The moving party, Masimo for this Motion, “bears the burden of demonstrating the absence of genuine issues of material fact.” Conroy v. Reebok Int’l, Ltd., 14 F.3d 1570, 1575 (Fed.Cir.1994). In reviewing Masimo’s motion for summary judgment of non-infringement, the Court must draw all reasonable inferences in favor of Nellcor. Overhead Door Corp. v. Chamberlain Group, Inc., 194 F.3d 1261, 1270 (Fed.Cir.1999).

Analysis

In any infringement analysis, the court must first determine the legal scope and meaning of the disputed claim terms. The court must then compare the accused device to the properly construed claims, to see whether the accused device contains all the limitations, either literally or by equivalents, that are in the claimed invention. *928 Johnson Worldwide Assocs., Inc. v. Zebco Corp., 175 F.3d 985, 988 (Fed.Cir.1999); Vitronics Corp. v. Conceptronic, Inc., 90 F.3d 1576, 1582 (Fed.Cir.1996).

The absence of a single claim limitation or its equivalent in the accused combination precludes infringement. Laitram Corp. v. Rexnord, Inc., 939 F.2d 1533, 1535 (Fed.Cir.1991). If a court does not find infringement of the independent claims, then a court may not find infringement of the dependant claims, either.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Brooks v. Metropolitan Life Insurance
526 F. Supp. 2d 534 (D. Maryland, 2007)
Nellcore Puritan Bennett, Inc. v. Masimo Corp.
402 F.3d 1364 (Federal Circuit, 2005)
Rosen Entertainment Systems, LP v. Eiger Vision
343 F. Supp. 2d 908 (C.D. California, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
300 F. Supp. 2d 923, 2004 U.S. Dist. LEXIS 4468, 2004 WL 117468, Counsel Stack Legal Research, https://law.counselstack.com/opinion/nellcor-puritan-bennett-inc-v-masimo-corp-cacd-2004.